###About ISHLTThe International Society for Heart and Lung Transplantation is a not-for-profit organization dedicated to promoting the science and treatment of end-stage cardiac and lung diseases. Created in 1981, the company now includes more than 2,300 members from over 45 countries, which involved a wide range of disciplines in the management and treatment of end-stage heart and lung diseases.
At this year’s meeting, Dr. Duncan will present data on the progress made in the development of the individual devices. Of 223 has reached its fifth year, the soon soon discuss reaching the clinical trial stage, as well as Duncan.In an accompanying editorial, said Dr. Keane of Medical University of South Carolina, the study only 50 percent patient response rate been not declaration that group size were inequality, and that improvement of 1.3 weeks can not be justified with increased costs. The authors proposed that the faster return in physical well-being can justify the elevated proceedings.